Search
for

    Sort by

    Research 361–390 of 1000+

    1. Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention Current Oncology · 2024
    2. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients Annals of Oncology · 2012 · 68 citations
    3. Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study Frontiers in Pharmacology · 2024 · 1 citations
    4. A Review Of Various Methods Of Treating Skin Cancer Based On The Use Of Bio-Based Materials World Journal of Medical Oncology · 2025
    5. Google allows advertisers to target the sensitive informational queries of cancer patients 2024
    6. Evaluation Of Comparative Efficacy Of Panchagavya Ghrita [ Oleation Therapy Versus Medicated Enema] With Amalakyadi Decoction Against Standard Control In Managing Side Effects of Chemo-Regiotherapy in Cancer Patients (Preprint) 2024
    7. Plasma Medicine: Innovative Methods of Diagnosis and Treatment of Chronic Wounds and Oncological Diseases SSP Modern Pharmacy and Medicine · 2025 · 5 citations
    8. Advances in hyaluronic acid-based biomaterials: applications in cancer therapy, wound healing, and disease management Journal of Materials Science Materials in Medicine · 2025 · 3 citations
    9. Care for alopecia during chemotherapy of cancer patients Korean Journal of Clinical Oncology · 2011 · 3 citations
    10. The Chemotherapy Use and Adverse Effects of Patients with Lung Cancer at Regional General Hospital in Surabaya, Indonesia Pharmaceutical Sciences and Research · 2026
    11. Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen Journal of Personalized Medicine · 2026
    12. Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion npj Breast Cancer · 2025
    13. Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance Cell stem cell · 2018 · 403 citations
    14. Hedgehog signalling in skin development and cancer Experimental Dermatology · 2006 · 190 citations
    15. A Case of Renin-Producing Adrenocortical Cancer. Endocrine Journal · 2000 · 14 citations
    16. Septin4 promotes cell death in human colon cancer cells by interacting with BAX International Journal of Biological Sciences · 2020 · 6 citations
    17. Eyelash trichomegaly complicating pembrolizumab for colorectal cancer Journal of Oncology Pharmacy Practice · 2025 · 2 citations
    18. A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation Research Square (Research Square) · 2023 · 1 citations
    19. A 3D microtumour system that faithfully represents ovarian cancer minimal residual disease bioRxiv (Cold Spring Harbor Laboratory) · 2023
    20. PO-0172 Behind Closed Doors: The Effects Of Childhood Cancer On Somatic Health Of Parents During And After Oncologic Therapy Archives of disease in childhood · 2014
    21. Multi-functional engineered polypeptide-based drug delivery systems for improved cancer therapy Green Chemical Engineering · 2022 · 11 citations
    22. Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions International Journal of Molecular Sciences · 2025 · 7 citations
    23. Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies Journal of Clinical Oncology · 2009 · 233 citations
    24. Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2 Research Square (Research Square) · 2021 · 1 citations
    25. Scalp Cooling for Chemotherapy-Induced Alopecia in Breast Cancer: A Recent Literature Review Indonesian Journal of Global Health Research · 2026
    26. ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability Zenodo (CERN European Organization for Nuclear Research) · 2026
    27. Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment The Journal of Dermatology · 2025
    28. Neoadjuvant Therapy with Disitamab Vedotin in Treating Muscle-Invasive Bladder Cancer: A Case Report SSRN Electronic Journal · 2022
    29. Alternative and Complimentary Medicines in the management of Chronic Breast Cancer: A discrete choice cost and clinical case report 2018
    30. 12. Cancer Journal of Cutaneous Medicine and Surgery · 2003